Viridian Therapeutics Price Chart
Viridian Therapeutics Volume Chart
Viridian Therapeutics Market Segments
After Hours
+0.06(+0.31%)
| Open | $19.40 |
|---|---|
| Close | $19.46 |
| Low | $19.08 |
| Low Change | -0.32 (-1.64%) |
| High | $19.56 |
| High Change | +0.16 (+0.82%) |
| Range | $0.48 |
| Volume | 350.559K |
| Dollar Volume | $6.82M |
Regular Trading Hours
+0.72(+3.83%)
| Open | $18.69 |
|---|---|
| Close | $19.41 |
| Low | $18.51 |
| Low Change | -0.18 (-0.96%) |
| High | $19.42 |
| High Change | +0.73 (+3.91%) |
| Range | $0.91 |
| Volume | 1.587M |
| Dollar Volume | $30.79M |
Premarket
+0.11(+0.59%)
| Open | $18.55 |
|---|---|
| Close | $18.66 |
| Low | $18.21 |
| Low Change | -0.34 (-1.83%) |
| High | $19.03 |
| High Change | +0.48 (+2.59%) |
| Range | $0.82 |
| Volume | 2.631K |
| Dollar Volume | $49.09K |
Overnight
*No Trades in Segment
After Hours Yesterday
+0.08(+0.42%)
| Open | $18.48 |
|---|---|
| Close | $18.56 |
| Low | $18.12 |
| Low Change | -0.36 (-1.94%) |
| High | $18.84 |
| High Change | +0.36 (+1.95%) |
| Range | $0.72 |
| Volume | 543.611K |
| Dollar Volume | $10.09M |
Regular Trading Hours Yesterday
-0.25(-1.33%)
| Open | $18.73 |
|---|---|
| Close | $18.48 |
| Low | $18.43 |
| Low Change | -0.31 (-1.63%) |
| High | $19.34 |
| High Change | +0.61 (+3.26%) |
| Range | $0.92 |
| Volume | 2.627M |
| Dollar Volume | $48.55M |
Premarket Yesterday
+0.17(+0.91%)
| Open | $18.60 |
|---|---|
| Close | $18.77 |
| Low | $18.42 |
| Low Change | -0.18 (-0.97%) |
| High | $19.60 |
| High Change | +1.00 (+5.38%) |
| Range | $1.18 |
| Volume | 80.985K |
| Dollar Volume | $1.52M |
Viridian Therapeutics News
4 days agoinvesting.comComcast, Viridian Therapeutics jump premarket; Doximity slips
2 months agoinvesting.comViridian Therapeutics stock surges on positive trial results
3 months agoinvesting.comViridian Therapeutics stock tumbles after Amgen Tepezza data
3 months agobloomberg.comUS Premarket Movers: Alcoa, Spire, Sysco, Viridian Therapeutics
3 months agoinvesting.comViridian Therapeutics stock tumbles despite trial success
Viridian Therapeutics Top Trades
Viridian Therapeutics's top trade so far today returned +7.41%, while the top short trade returned -2.73%.
Viridian Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $18.58 |
|---|---|
| 10 Day Moving Average (SMA10) | $17.92 |
| 20 Day Moving Average (SMA20) | $17.04 |
| 50 Day Moving Average (SMA50) | $16.46 |
| 100 Day Moving Average (SMA100) | $20.49 |
| 200 Day Moving Average (SMA200) | $24.08 |
Viridian Therapeutics Statistics
| Average Volume (30 Days) | 2.2M |
|---|---|
| P/E Ratio (Current) | -6.72 |
| EPS (Current) | -$2.75 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$303.82M |
| Cash Ratio | 3.40 |
| Current Ratio | 15.15 |
| Quick Ratio | 15.15 |
| Debt to Equity | 0.14 |
| Enterprise Value | $1.95B |
| EV to EBITDA | -5.06 |
| EV to Sales | 27.51 |
| Price to Book | 3.21 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 28.78 |
| Return on Assets | -0.38% |
| Return on Equity | -0.48% |
Viridian Therapeutics Stock Splits
There have been 2 stock splits for Viridian Therapeutics (VRDN). The last reverse stock split occured on November 13, 2020 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Nov 13, 2020 | Reverse | 15:1 |
| Nov 7, 2016 | Reverse | 15:1 |
Viridian Therapeutics Dividends
There have been no dividends for Viridian Therapeutics (VRDN).